Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003). "Cystatins". Biochemical Society Symposium. 70 (70): 179–199. doi:10.1042/bss0700179. PMID14587292.
Machleidt W, Borchart U, Fritz H, Brzin J, Ritonja A, Turk V (November 1983). "Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes". Hoppe-Seyler's Zeitschrift für physiologische Chemie. 364 (11): 1481–1486. doi:10.1515/bchm2.1983.364.2.1481. PMID6689312.
Kocevar N, Obermajer N, Kreft S (September 2008). "Membrane permeability of acylated cystatin depends on the fatty acyl chain length". Chemical Biology & Drug Design. 72 (3): 217–224. doi:10.1111/j.1747-0285.2008.00693.x. PMID18702630. S2CID24573152.
Abrahamson M, Alvarez-Fernandez M, Nathanson CM (2003). "Cystatins". Biochemical Society Symposium. 70 (70): 179–199. doi:10.1042/bss0700179. PMID14587292.
Machleidt W, Borchart U, Fritz H, Brzin J, Ritonja A, Turk V (November 1983). "Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes". Hoppe-Seyler's Zeitschrift für physiologische Chemie. 364 (11): 1481–1486. doi:10.1515/bchm2.1983.364.2.1481. PMID6689312.
Kocevar N, Obermajer N, Kreft S (September 2008). "Membrane permeability of acylated cystatin depends on the fatty acyl chain length". Chemical Biology & Drug Design. 72 (3): 217–224. doi:10.1111/j.1747-0285.2008.00693.x. PMID18702630. S2CID24573152.
Kocevar N, Obermajer N, Kreft S (September 2008). "Membrane permeability of acylated cystatin depends on the fatty acyl chain length". Chemical Biology & Drug Design. 72 (3): 217–224. doi:10.1111/j.1747-0285.2008.00693.x. PMID18702630. S2CID24573152.